Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Clinical Trial Insights In SURMOUNT-1 and SURPASS trials, Mounjaro showed: Up to 22.5% body weight reduction in non-diabetic obese patients Greater HbA1c reductions vs Ozempic and insulin in diabetics Reference : Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Reference : mounjaro.lilly.com/hcp/a1c-weight FDA approved Mounjaro for Type 2 Diabetes in 2022, and later for weight loss under the brand Zepbound in Nov 2023 (US)
Prepared vials should remain refrigerated between 2-8C and protected from repeated temperature changes
Mechanism of Action: DSIP acts on the central nervous system, helping to modulate sleep-wake cycles, particularly enhancing deep (delta) sleep
By modulating key enzymes, boosting melatonin output, and resetting clock gene expression, Epitalon may function as a chronobiotic peptide, realigning internal time to preserve physiological harmony
